低血清总胆固醇水平预测早期多重系统缩的死亡率:一个前性队列研究
Jingxuan Huang1, Lingyu Zhang1, Qirui Jiang1
1Laboratory of Neurodegenerative Disorders, Department of Neurology, Rare Diseases Center, West China Hospital, Sichuan University, Chengdu, China.
Frontiers in nutrition
|November 13, 2025
概括
血清总胆固醇 (TC) 影响多重系统缩 (MSA) 的生存率. 较低的TC水平与更短的生存时间有关,在早期MSA患者中确定了降低死亡风险的最佳水平.
科学领域:
- 神经学 神经学
- 临床生物化学 临床生物化学
背景情况:
- 血清总胆固醇 (TC) 与多重系统缩 (MSA) 风险有关.
- 血清TC对MSA患者死亡率的影响需要进一步调查.
- 了解这种关系对于早期的MSA管理至关重要.
研究的目的:
- 为了确定基线血清TC水平和早期MSA患者的存活率之间的关联.
- 澄清血清TC对MSA死亡率的预测值.
- 探索血清TC和生存率之间的非线性关系.
主要方法:
- 分析了364名早期MSA患者.
- 患者按血清TC三位数分组.
- 使用了卡普兰-梅尔,考克斯回归和受限制立方支线分析.
主要成果:
- 较低的血清TC水平与较短的生存时间相关 (Log-rank p=0.004).
- 中间TC水平显示死亡风险降低 (HR:0.47;95%CI:0.23-0.96).
- 观察到一种非线性关系,4.38 mmol/L血清TC的死亡风险最低.
结论:
- 基线血清TC与MSA患者的存活率负相关.
- 血清TC是早期MSA死亡率的重要预测因素.
- 针对特定的TC水平可能会改善MSA患者的结果.
相关概念视频
Blood Studies for Cardiovascular System III: Serum Lipid Profile
540
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
540
Atherosclerosis III: Management
307
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
307
Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
450
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
450
Lipids: Dietary Sources and Requirements
1.8K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.8K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
525
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
525

